Literature DB >> 31271740

Deoxythymidylate kinase, DTYMK, is a novel gene for mitochondrial DNA depletion syndrome.

Ching-Wan Lam1, Wai-Lan Yeung2, Tsz-Ki Ling3, Ka-Chung Wong3, Chun-Yiu Law3.   

Abstract

BACKGROUND: Mitochondrial DNA depletion syndrome is a group of heterogeneous diseases with non-specific presentation. The common feature is the quantitative depletion of mitochondrial DNA without qualitative defects. Diagnosis of these diseases poses a challenge and whole exome sequencing is often needed for their diagnoses. CASE: Two siblings of a quartet family, presenting with hypotonia, microcephaly and severe intellectual disability, have been diagnosed to harbor two heterozygous variants in trans in the DTYMK gene of the thymidine biosynthesis pathway. Mitochondrial DNA depletion has been demonstrated in silico in the more severe sibling.
CONCLUSIONS: We suggest the consideration of incorporating DTYMK as one of the associated genes of mitochondrial DNA depletion syndrome (MDDS). DTYMK may be the missing link in the mitochondrial nucleotide salvage pathway but further characterization and additional evidence would be needed.
Copyright © 2019 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Clinical whole-exome sequencing; DTYMK; Mitochondrial DNA depletion syndrome; Salvage pathway

Year:  2019        PMID: 31271740     DOI: 10.1016/j.cca.2019.06.028

Source DB:  PubMed          Journal:  Clin Chim Acta        ISSN: 0009-8981            Impact factor:   3.786


  6 in total

1.  DTYMK is essential for genome integrity and neuronal survival.

Authors:  Jo M Vanoevelen; Jörgen Bierau; Janine C Grashorn; Ellen Lambrichs; Erik-Jan Kamsteeg; Levinus A Bok; Ron A Wevers; Marjo S van der Knaap; Marianna Bugiani; Junmei Hu Frisk; Rita Colnaghi; Mark O'Driscoll; Debby M E I Hellebrekers; Richard Rodenburg; Carlos R Ferreira; Han G Brunner; Arthur van den Wijngaard; Ghada M H Abdel-Salam; Liya Wang; Constance T R M Stumpel
Journal:  Acta Neuropathol       Date:  2021-12-17       Impact factor: 17.088

2.  MiR-148b-3p Regulates the Expression of DTYMK to Drive Hepatocellular Carcinoma Cell Proliferation and Metastasis.

Authors:  Guifang He; Jing Qiu; Changchang Liu; Ben Tian; Duo Cai; Shihai Liu
Journal:  Front Oncol       Date:  2021-12-24       Impact factor: 6.244

3.  Biochemical Characterizations of Human TMPK Mutations Identified in Patients with Severe Microcephaly: Single Amino Acid Substitutions Impair Dimerization and Abolish Their Catalytic Activity.

Authors:  Junmei Hu Frisk; Jo M Vanoevelen; Jörgen Bierau; Gunnar Pejler; Staffan Eriksson; Liya Wang
Journal:  ACS Omega       Date:  2021-12-06

4.  Differential expression of enzymes in thymidylate biosynthesis in zebrafish at different developmental stages: implications for dtymk mutation-caused neurodegenerative disorders.

Authors:  Junmei Hu Frisk; Stefan Örn; Gunnar Pejler; Staffan Eriksson; Liya Wang
Journal:  BMC Neurosci       Date:  2022-03-27       Impact factor: 3.288

5.  Deoxythymidylate Kinase as a Promising Marker for Predicting Prognosis and Immune Cell Infiltration of Pan-cancer.

Authors:  Tianfeng Lan; Yachao Wang; Jinxin Miao; Haoran Guo; Zheng Wang; Jianyao Wang; Chunyang Zhang; Panpan Yang; Zhongxian Zhang; Louisa Chard Dunmall; Yaohe Wang
Journal:  Front Mol Biosci       Date:  2022-07-12

6.  Prognostic Value of a Novel Signature With Nine Hepatitis C Virus-Induced Genes in Hepatic Cancer by Mining GEO and TCGA Databases.

Authors:  Jianming Wei; Bo Wang; Xibo Gao; Daqing Sun
Journal:  Front Cell Dev Biol       Date:  2021-07-16
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.